Asston Pharmaceuticals IPO Subscription
The Asston Pharmaceuticals IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
As per the latest subscription update, the Asston Pharmaceuticals IPO has received bids for 27,86,91,000 shares against 21,28,000 shares offered, resulting in an overall subscription of 130.96x. the NII category is subscribed 353.5x, Retail Investors 172.14x, and QIBs 34.39x.
- Retail
- 172.14x
- NII
- 353.5x
- QIB
- 34.39x
- Total
- 130.96x
Current GMP
₹26 (+21.14%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Asston Pharmaceuticals IPO Subscription Details ( Fri, 11 Jul 25 01:27 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 1,060,000 | 36,449,000 | 34.39x |
| Non-Institutional | 322,000 | 113,826,000 | 353.5x |
| Retail Investors | 746,000 | 128,416,000 | 172.14x |
| Total | 2,128,000 | 278,691,000 | 130.96x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved Apps | Applied Apps | Times (x) |
|---|---|---|---|
| Non-Institutional | - | 15,073 | - |
| Retail Investors | - | 64,208 | - |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Asston Pharmaceuticals IPO Live Subscription Status?
You can check the Asston Pharmaceuticals IPO live subscription status on the IPO Master App or the official websites of the BSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Asston Pharmaceuticals IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Asston Pharmaceuticals IPO was subscribed 172.14 times as of Fri, Jul 11, 2025 06:57 PM. The public issue closed on Fri, Jul 11, 2025 for bidding.
How to subscribe Asston Pharmaceuticals IPO?
Investors can apply for the Asston Pharmaceuticals IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Asston Pharmaceuticals IPO subscribed?
The Asston Pharmaceuticals IPO was subscribed 130.96x times at the close of bidding period on Fri, Jul 11, 2025.
How to check Asston Pharmaceuticals IPO allotment?
The Asston Pharmaceuticals IPO allotment was finalized on Mon, Jul 14, 2025. You can check the Asston Pharmaceuticals IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Asston Pharmaceuticals IPO Be Listed?
The Asston Pharmaceuticals IPO was listed on Wed, Jul 16, 2025, on the BSE.
What is the Asston Pharmaceuticals IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Asston Pharmaceuticals IPO was subscribed 34.39 times as of Fri, Jul 11, 2025 06:57 PM.